Synthesis of various cyclopropyl methyl bromide and its derivatives from ketones and/or aldehydes and some β-dicarbonyl compounds in the presence of BrCN and Et3N
作者:Saeed Gholizadeh、Kazem D. Safa、Nader Noroozi Pesyan
DOI:10.1007/s13738-019-01600-x
日期:2019.6
aldehydes with ethyl cyanoacetate or malononitrile and cyanogen bromide (BrCN) in the presence of Et3N to give products in excellent yields within about 3 s. All structures were characterized by IR, 1H-NMR, 13C-NMR, and Mass spectroscopy techniques. The reaction mechanism was discussed.
Discovery of full color emissive thiazole fluorophores in solution and solid states: The core is central and regulating torsional barrier does the trick!
作者:Rakesh Radhakrishnan、Bhavya Bini Sinu、Vishnu Anilkumar、K.G. Sreejalekshmi
DOI:10.1016/j.dyepig.2020.108560
日期:2020.10
core with solid and solution state emissions were designed. Stable conformers were predicted computationally and C4 substituent on the 1,3-thiazole ring emerged crucial as multifunctional stacking modulator in the multidirectional charge transfer donor-acceptor systems. Seven novel molecules were synthesized, and their emissions with very good quantum yield both in solution and solidstates were reported
PHENYL-OXAZOLYL DERIVATIVES, PREPARATION METHOD THEREOF, AND RELATED APPLICATION OF THE PHENYL-OXAZOLYL DERIVATIVES AS AN IMPDH INHIBITOR
申请人:INSTITUTE OF MEDICINAL BIOTECHNOLOGY, CHINESE ACADEMY OF MEDICAL SCIENCES
公开号:US20150031686A1
公开(公告)日:2015-01-29
Disclosed are phenyl-oxazolyl derivatives having a general formula (I), a preparation method thereof, and an application of the phenyl-oxazolyl derivatives as an inosine monophosphate dehydrogenase (IMPDH) inhibitor.
Disclosed is an extracellular matrix genetranscription inhibitor composition or the like characterized by containing a cinnamoyl compound represented by the formula(I) below:
and an inert carrier.
揭示了一种包含下面式(I)所代表的肉桂酰化合物和惰性载体的细胞外基质基因转录抑制剂组合物或类似物。
Anti-cancer phosphonate analogs
申请人:Boojamra G. Constantine
公开号:US20060079478A1
公开(公告)日:2006-04-13
The invention is related to phosphorus substituted anti-cancer compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.